↓ Skip to main content

Advances in Cancer Biomarkers

Overview of attention for book
Cover of 'Advances in Cancer Biomarkers'

Table of Contents

  1. Altmetric Badge
    Book Overview
  2. Altmetric Badge
    Chapter 1 Cancer Biomarkers: A Status Quo
  3. Altmetric Badge
    Chapter 2 Cancer Biomarkers Discovery and Validation: State of the Art, Problems and Future Perspectives
  4. Altmetric Badge
    Chapter 3 Use of Biomarkers in Screening for Cancer.
  5. Altmetric Badge
    Chapter 4 The Role of Metabolomics in the Study of Cancer Biomarkers and in the Development of Diagnostic Tools
  6. Altmetric Badge
    Chapter 5 The Role of Epigenomics in the Study of Cancer Biomarkers and in the Development of Diagnostic Tools.
  7. Altmetric Badge
    Chapter 6 Efficient, Adaptive Clinical Validation of Predictive Biomarkers in Cancer Therapeutic Development
  8. Altmetric Badge
    Chapter 7 Prostate Specific Antigen as a Tumor Marker in Prostate Cancer: Biochemical and Clinical Aspects
  9. Altmetric Badge
    Chapter 8 The Actual Role of LDH as Tumor Marker, Biochemical and Clinical Aspects
  10. Altmetric Badge
    Chapter 9 Neuron-Specific Enolase as a Biomarker: Biochemical and Clinical Aspects
  11. Altmetric Badge
    Chapter 10 Components of the Plasminogen-Plasmin System as Biologic Markers for Cancer
  12. Altmetric Badge
    Chapter 11 The Role of Human Chorionic Gonadotropin as Tumor Marker: Biochemical and Clinical Aspects.
  13. Altmetric Badge
    Chapter 12 Advances in Cancer Biomarkers
  14. Altmetric Badge
    Chapter 13 Mucins and Cytokeratins as Serum Tumor Markers in Breast Cancer
  15. Altmetric Badge
    Chapter 14 The Role of CA 125 as Tumor Marker: Biochemical and Clinical Aspects
  16. Altmetric Badge
    Chapter 15 CA 19-9: Biochemical and Clinical Aspects.
  17. Altmetric Badge
    Chapter 16 Non Coding RNA Molecules as Potential Biomarkers in Breast Cancer
  18. Altmetric Badge
    Chapter 17 Urinary Prostate Cancer Antigen 3 as a Tumour Marker: Biochemical and Clinical Aspects
  19. Altmetric Badge
    Chapter 18 Biomarker in Cisplatin-Based Chemotherapy for Urinary Bladder Cancer
  20. Altmetric Badge
    Chapter 19 A Critical Approach to Clinical Biochemistry of Chromogranin A.
  21. Altmetric Badge
    Chapter 20 The Actual Role of Receptors as Cancer Markers, Biochemical and Clinical Aspects: Receptors in Breast Cancer
  22. Altmetric Badge
    Chapter 21 The Role of CTCs as Tumor Biomarkers
Attention for Chapter 8: The Actual Role of LDH as Tumor Marker, Biochemical and Clinical Aspects
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Above-average Attention Score compared to outputs of the same age and source (60th percentile)

Mentioned by

twitter
2 X users

Citations

dimensions_citation
31 Dimensions

Readers on

mendeley
176 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Chapter title
The Actual Role of LDH as Tumor Marker, Biochemical and Clinical Aspects
Chapter number 8
Book title
Advances in Cancer Biomarkers
Published in
Advances in experimental medicine and biology, January 2015
DOI 10.1007/978-94-017-7215-0_8
Pubmed ID
Book ISBNs
978-9-40-177214-3, 978-9-40-177215-0
Authors

Vladimir Jurisic, Sandra Radenkovic, Gordana Konjevic, Jurisic, Vladimir, Radenkovic, Sandra, Konjevic, Gordana

Abstract

Lactate dehydrogenase (LDH) among many biochemical parameters represents a very valuable enzyme in patients with cancer with possibility for easy routine measurement in many clinical laboratories. Previous studies where mostly based on investigated LDH in serum of patients with cancer with aims to estimate their clinical significance. The new directions in investigation of LDH where based on the principle that tumor cells release intracellular enzymes trough damaged cell membrane, that is mostly consequence in intracellular mitochondrial machinery alteration, and apoptosis deregulation. This consideration can be used not only in-vitro assays, but also in respect to clinical characteristics of tumor patients. Based on new techniques of molecular biology it is shown that intracellular characteristics of LDH enzyme are very sensitive indicators of the cellular metabolic state, aerobic or anaerobic direction of glycolysis, activation status and malignant transformation. Using different molecular analyses it is very useful to analyzed intracellular LDH activity in different cell line and tumor tissues obtained from patients, not only to understanding complexity in cancer biochemistry but also in early clinical diagnosis. Based on understandings of the LDH altered metabolism, new therapy option is created with aims to blocking certain metabolic pathways and stop tumors growth.

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 176 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 176 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 33 19%
Student > Master 17 10%
Researcher 14 8%
Other 9 5%
Student > Ph. D. Student 9 5%
Other 19 11%
Unknown 75 43%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 34 19%
Medicine and Dentistry 28 16%
Agricultural and Biological Sciences 15 9%
Pharmacology, Toxicology and Pharmaceutical Science 7 4%
Chemistry 5 3%
Other 7 4%
Unknown 80 45%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 09 April 2020.
All research outputs
#16,007,841
of 25,320,147 outputs
Outputs from Advances in experimental medicine and biology
#2,310
of 5,281 outputs
Outputs of similar age
#200,772
of 365,307 outputs
Outputs of similar age from Advances in experimental medicine and biology
#101
of 275 outputs
Altmetric has tracked 25,320,147 research outputs across all sources so far. This one is in the 34th percentile – i.e., 34% of other outputs scored the same or lower than it.
So far Altmetric has tracked 5,281 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.9. This one has gotten more attention than average, scoring higher than 53% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 365,307 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 42nd percentile – i.e., 42% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 275 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 60% of its contemporaries.